Elsevier

Gynecologic Oncology

Volume 80, Issue 2, February 2001, Pages 139-144
Gynecologic Oncology

Regular Article
Occult Lymph Node Metastases Detected by Cytokeratin Immunohistochemistry Predict Recurrence in Node-Negative Endometrial Cancer

https://doi.org/10.1006/gyno.2000.6067Get rights and content

Abstract

Objective. Even after curative resection of early endometrial cancer, some patients die as a result of recurrence. We believe that these patients likely had occult lymph node metastases at the time of diagnosis. In an attempt to identify the responsible occult metastases, the clinicopathological significance of cytokeratin expression in lymph nodes with unconfirmed metastasis was evaluated retrospectively in patients with endometrial carcinoma.

Methods. We examined 304 pelvic lymph nodes and 46 primary tumors excised from 46 patients with endometrial cancer, including 36 with Stage I disease and 10 with Stage IIIc disease. Formalin-fixed paraffin-embedded tissue sections were stained immunohistochemically using antibodies against cytokeratin, CA125, and macrophage-related antigen. Sections were also stained with hematoxylin and eosin.

Results. In 10 patients with Stage IIIc disease, cytokeratin expression was detected in cells other than the tumor cells in all 13 lymph nodes with metastasis and also in 20 (30.3%) of 66 lymph nodes without metastasis. Cytokeratin expression was observed in 37 (16.4%) of 225 lymph nodes with unconfirmed metastasis, which were obtained from 14 of 36 patients with Stage I disease. Five of fourteen patients with lymph nodes expressing cytokeratin had recurrent disease in the pelvic cavity, while all 22 patients with unconfirmed cytokeratin expression in their lymph nodes showed no recurrence. Cytokeratin and CA125 were detected simultaneously on macrophages in lymph nodes. Cytokeratin expression in lymph nodes was closely related to lymph-vascular space involvement of the primary tumor, but was not related to either histological grade or depth of myometrial invasion. Multivariate analysis identified cytokeratin expression as an independent risk factor for recurrence in Stage I endometrial cancer.

Conclusions. The immunohistochemical expression of cytokeratin in lymph nodes with undetected metastases predicts occult metastasis to these nodes and is a risk factor for recurrence in early-stage endometrial cancer.

References (21)

There are more references available in the full text version of this article.

Cited by (118)

  • Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional study

    2021, Gynecologic Oncology
    Citation Excerpt :

    For example, 4 of the 14 f ITC patients with NE had recurrence by 4 years despite receiving ATx. Although these pathologic criteria are well established as risk factors among patients with node-negative and node-positive EC [17,18], their utility and role in risk-stratifying disease progression among LVM patients is just beginning to be elicited [19,20]. Similar to our study, Aloisi et al. [21] retrospectively examined risk factors for recurrence among 79 LVM patients with a 97.2% ATx rate.

  • Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?

    2021, Gynecologic Oncology
    Citation Excerpt :

    Although several studies to date have examined the significance of ITCs, all are limited by small numbers of patients with ITCs and most patients received adjuvant therapy. Two studies (cohorts of patients between 1986 and 1995 [17] and 1997–2004 [18]) retrospectively performed ultrastaging on all lymph nodes of patients with stage I or II disease. These studies reported that occult (IHC positive) lymph node metastases were associated with LVSI [17,18] and deep myometrial invasion [18].

View all citing articles on Scopus
1

To whom correspondence should be addressed. Fax: +81-561-62-2991. E-mail: [email protected].

View full text